Nanosecond-Scale Proton Emission from Strongly Oblate-Deformed

Using the fusion-evaporation reaction ^{96}Ru(^{58}Ni,p4n)^{149}Lu and the MARA vacuum-mode recoil separator, a new proton-emitting isotope ^{149}Lu has been identified. The measured decay Q value of 1920(20) keV is the highest measured for a ground-state proton decay, and it naturally leads to the shortest directly measured half-life of 450_{-100}^{+170} ns for a ground-state proton emitter. The decay rate is consistent with l_{p}=5 emission, suggesting a dominant πh_{11/2} component for the wave function of the proton-emitting state. Through nonadiabatic quasiparticle calculations it was concluded that ^{149}Lu is the most oblate deformed proton emitter observed to date.

Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments.

OBJECTIVE: The study aimed at investigating the quality of life (QoL) and physical performance and activity, and their interrelations, in Finnish female breast cancer patients shortly after adjuvant treatments. METHODS: A total of 537 disease-free breast cancer survivors aged 35-68 years were surveyed at the beginning of a one year randomized exercise intervention. The patients were interviewed using EORTC QLQ-C30, FACIT-F, RBDI, and WHQ (for vasomotor symptoms) questionnaires. Physical performance was tested by a 2 km walking test. Physical activity was measured by a questionnaire and a prospective two-week diary. Multivariate analysis was used to study the factors associated with QoL. RESULTS: About 26% of the patients were rated as depressed, 20.4% as fatigued, and 82% suffered from menopausal symptoms. The global QoL was lower than in general population (69.4 vs 74.7, p<0.001). About 62% of the walking test results were below the population average. Fatigue (p<0.001), depression (p<0.001), body mass index (p = 0.016) and comorbidity (p = 0.032) impaired, and physical activity (p = 0.003) improved QoL. Physical activity level correlated positively to physical performance (r = -0.274, p<0.0001). CONCLUSIONS: The QoL of the patients shortly after adjuvant treatments was impaired and the physical performance poor as compared to general population. In particular, depression and fatigue were related to impaired QoL. Physical performance and activity level were the only factors that correlated positively to QoL. Thus, physical exercise could be useful in rehabilitation of cancer survivors, especially for depressed and fatigued patients.

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.

The purpose of this study was to evaluate the effects of two alternative chemotherapy regimes on the quality of life (QoL) of patients with advanced breast cancer. In a multicentre trial, 283 patients were randomised to receive either docetaxel (T) or sequential methotrexate and 5-fluorouracil (MF). QoL was assessed at baseline and before each treatment using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). Initial compliance in the QoL study was 96% and the overall compliance 82%. QoL data were available for 245 patients (T 130 and 115 MF). Both treatment groups showed some improvement in emotional functioning during treatment, with a significant difference favouring the MF group at treatment cycles 5 and 6. In the T group, the scores on the other functional scales remained stable throughout the first six cycles. There were significant differences favouring the MF group on the social functioning scale at treatment cycle 6 and on the Global QoL scale at treatment cycles 5 and 6. On most symptom and single-item scales there were no statistically significant differences between the groups. However, at baseline, the T patients reported more appetite loss, at treatment cycles 2-4, the MF patients reported more nausea/vomiting, and at treatment cycle 6, the T patients reported more symptoms of fatigue, dyspnoea and insomnia. There were no statistically significant differences between the groups in the mean change scores of the functional and symptom scales. Interindividual variance was, however, larger in the T group. Differences in QoL between the two treatment groups were minor. Hence, given the expectancy of comparable QoL outcomes, the choice of treatment should be made on the basis of the expected clinical effect.

Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.

The purpose of the study was to investigate whether baseline quality of life (QoL) and changes in QoL scores from baseline are prognostic for time to progression (TTP) and/or overall survival (OS) in patients with advanced breast cancer receiving docetaxel (T) or sequential methotrexate and 5-fluorouracil (MF). QoL was assessed at baseline and before each treatment using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). Survival curves and probabilities were estimated using the Kaplan-Meier technique. The Cox proportional hazards regression model was used for both the univariate and multivariate analyses to explore relationships between baseline QoL variables and TTP, as well as OS. In the univariate analysis, more severe pain and fatigue at baseline were predictive for a shorter OS; global QoL, physical functioning and appetite loss had a borderline significance (P=0.0130 for global QoL; P=0.0256 for physical functioning: P=0.0149 for appetite loss). World Health Organization (WHO) performance status was significantly predictive for OS. In the multivariate analysis, more severe pain at baseline was predictive for a shorter OS. In contrast, baseline QoL had no prognostic value for the duration of TTP. QoL change scores from baseline QoL predicted neither OS nor TTP. Our findings suggest that while QoL measurements are important in evaluating patients' QoL, they have no great importance in predicting primary clinical endpoints such as TTP or OS in advanced breast cancer patients.

Some factors causing mortality among female minks during the puerperium and lactation periods.

The purpose of this study, in which the farm was used as the statistical unit, was to find factors affecting mink mortality under farm conditions. Mortality was hypothesised to be affected by factors including, among others, variables describing the amount (level) and variation in composition and quality of the feed. Other explanatory variables applied in the study included farm size and age. Factor analyses were performed for variables of feed composition and quality in order to condense the variable information and to facilitate the selection of explanatory variables. This report presents a preliminary regression model for female mink mortality factors describing feed level and variation, and farm size, as explanatory variables. The regression model emphasized among other factors the importance of a constant albumin quality and a constant energy level.

Autocorrelation and variability of indoor air quality measurements.

Measurements of gaseous and particulate concentrations are used to characterize the indoor environment, but such measurements may reflect temporary conditions that are not representative of longer time periods. Moreover, indoor air quality (IAQ) measurements are autocorrelated, a result of limited mixing and air exchange, cyclic emissions, HVAC operation, and other factors. This article analyzes the autocorrelation and variability of IAQ measurements using time series analysis techniques in conjunction with a simple IAQ model. Autocorrelations may be estimated using the air exchange rate (alpha) and ventilation effectiveness (epsilon) of the building or room under study, or estimated from pollutant measurements. From this, the variability, required sample size, and other sampling parameters are estimated. The method is tested in a case study in which particle number, fungi, bacteria, and carbon dioxide concentrations were continuously measured in an office building over a 1-week period. The estimated air exchange rate (1.4/hr) for area studied was predicted to yield autocorrelation coefficients of approximately 0.5 for measurements collected on 30-min intervals. Autocorrelation coefficients based on airborne measurements (lag 0.5 hr) ranged from 0.5 to 0.7 for 1-25 microm diameter particles, fungi, and CO2, but near zero for particles < or =1 microm diameter and bacteria. As expected, the variability of measurements with the lowest autocorrelation decreased the most at long sampling times. The implications for spaces with low alpha * epsilon products are that measurements may not benefit significantly from longer averaging periods, measurements on any single day may not be representative, and day-to-day variability may be significant. Steps to determine sample sizes, averaging times, and sampling strategies that can improve the representativeness of IAQ measurements are discussed.

Endotoxin-altering activity of plasma does not affect antigenicity of native protoplasmic polysaccharide.

The capacity to precipitate quantitatively with homologous antiserum of native protoplasmic polysaccharide from Escherichia coli was not reduced by incubation in human plasma; it was reduced with the immunochemically related lipopolysaccharide.

Characterization of particulate emissions from occupant activities in offices.

This paper characterizes the relationship between occupant activities and indoor air particulate levels in a non-smoking office building. Occupant activities were recorded on video. Particulate concentrations were monitored by three optical particle counters (OPCs) in five size ranges at three heights. Particulate mass concentrations were measured gravimetrically and bioaerosol concentrations were determined by impaction methods. Occupant activities and number concentrations were determined with 1-min resolution over a 1-week period. Occupant activities such as walking past or visiting the monitoring site explained 24-55% of the variation of 1- to 25-micron diameter particle number concentrations. Statistical models associating particulate concentrations with occupant activities depended on the size fraction and included an autocorrelative term. Occupant activities are estimated to contribute up to 10 micrograms m-3 in particulate concentrations per person. Number concentrations of particles smaller than 1 micron had little correlation with indoor activities other than cigarette smoking and were highly correlated with outdoor levels. The method can be used to characterize emissions from activities if rapid measurements can be made and if activities can be coded from the video record.

Radioimmunoassay for quantifying antibody to N. Gonorrhoeae in human sera.

A radioimmunoassay has been developed for the serodiagnosis of gonorrhoea. When 382 human sera from acutely infected and well documented control subjects were assayed by this procedure, 90% were diagnosed correctly, 5% were diagnosed incorrectly, and in 5% the results were indecisive.

Preparation and properties of a national reference endotoxin.

A large pool of refined endotoxin was prepared from Escherichia coli O113 by extraction with hot acqueous phenol. It was characterized chemically and biologically and will be available for a reference standard designated as reference endotoxin EC.

Timing of quality of life (QoL) assessments as a source of error in oncological trials.

AIM OF THE STUDY: To produce an empirical estimate of the nature and magnitude of the error produced by incorrect timing quality of life (QoL) measurements in patients receiving chemotherapy. DESIGN: In a multicentre trial, 283 patients were randomized to receive either docetaxel (T) or sequential methotrexate and 5-fluorouracil (MF). The QoL was assessed at baseline and before each treatment using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). The study design was retrospective. Data were analysed using t-tests. RESULTS: Erroneous timing affected the QoL findings in both treatment arms. At baseline, there were statistically significant differences in the MF group on the nausea/vomiting scale, with ill-timed assessment showing more symptoms, and in the T group on the physical functioning scale with ill-timed assessments indicating better QoL. The mean scores of correct vs. incorrect timings over the first 14 cycles showed statistically significant differences on several scales. In the MF group, ill-timed assessments indicated significantly worse physical functioning and global QoL, and significantly more of the following symptoms: fatigue, nausea/vomiting, insomnia, appetite loss, and constipation. In the T group, ill-timed assessment showed better physical functioning, less dyspnoea and more insomnia than correctly timed assessments. The reasons for erroneous timing were not always detectable retrospectively. However, in some cases the MF group, being in standard treatment, seemed to have followed a clinical routine not involving the active participation of the study nurse responsible, whereas patients in the experimental T group were more consistently taken care of by the study nurses. CONCLUSIONS: Incorrect timing of QoL assessments in oncological trials jeopardises both the reliability of the QoL findings within treatment and the validity of QoL outcome comparisons between treatments. This issue should be emphasized in the planning of both the study design and clinical routines.